Dr. Michael P. Siano, D.C. Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 34 Halls Mills Rd, Whiting, ME 04691 Phone: 207-259-0173 Fax: 770-565-9776 |
News Archive
Alnylam Pharmaceuticals, Inc. a leading RNAi therapeutics company, announced today the publication of new research findings in the journal Nature describing the discovery and validation of the role of the gene Sort1 in the development of cardiovascular disease, including myocardial infarction (MI). This work was done with collaborators at University of Pennsylvania (UPenn) School of Medicine, Massachusetts General Hospital (MGH), and the Broad Institute. The collaborative effort combined genome-wide association studies (GWAS) and RNAi technology to identify and validate novel genes as targets for new therapies for heart disease.
Originally, the label "borderline personality disorder" was applied to patients who were thought to represent a middle ground between patients with neurotic and psychotic disorders. Increasingly, though, this area of research has focused on the heightened emotional reactivity observed in patients carrying this diagnosis, as well as the high rates with which they also meet diagnostic criteria for posttraumatic stress disorder and mood disorders.
EveryWare Ltd, the real-time analytics specialist, has ‘leapt forward' in time at IoT Tech Expo Europe 2016, taking place today in London.
The speed at which breasts move during exercise could be key to understanding breast pain, according to an expert at the University of Portsmouth.
› Verified 2 days ago